Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nutraceutical International

This article was originally published in The Tan Sheet

Executive Summary

Park City, Utah-based supplement firm is the subject of a patent infringement suit by Swiss firm Lonza in New York district court for enteric preparations of L-carnitine L-tartarate. Lonza claims the U.S. Patent Office confirmed the validity of its patent "against an attack by an admitted infringer." Nutraceutical filed a complaint against Lonza in Utah district court March 2 for declaratory judgment of non-infringement, invalidity and non-enforceability of Lonza's patent. The firm estimates sales of the allegedly infringing carnitine products at less than 1% of FY 2003 sales...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS096724

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel